CBD can help ease chronic pain, anxiety, and mood disorders

Cannabidiol (CBD) is emerging as the future of medicinal cannabis, as new research uncovers how it works with brain receptors to affect anxiety and pain management.

Unlike its psychoactive cousin, THC, cannabidiol has the potential for therapy without the high.

Scientists have long hypothesized about CBD’s functional mechanisms, but a recent breakthrough has provided new insight into how it fine-tunes key biological processes.

While research on cannabis has intensified recently, there is still much to understand regarding the ways in which the plant components interact in the body.

In a significant advance, researchers have now looked more closely at what researchers are characterizing as a highly complex interplay between CBD and THC that opens new avenues for using the benefits with fewer of the negatives.

Introducing the power of CBD and THC

A team of researchers from the University of Mississippi’s National Center for Natural Products Research has investigated the complex relationship between cannabidiol (CBD) and tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis.

Their study sheds new light on how these compounds interact with the body’s cellular receptors, potentially revolutionizing pain and anxiety treatments.

As demand for CBD products surges in the U.S., following hemp’s decriminalization by the Agricultural Improvement Act of 2018, it as become critical to understand these interactions.

“The 2018 Farm Bill passage effectively opened a Pandora’s box of research challenges,” said Amar Chittiboyina, principal scientist and associate director of the Center.

“CBD’s use proliferated across a wide spectrum, from pain management and recreational purposes to seemingly endless other applications. However, the fundamental question lies in understanding how CBD works on various targets and exerts its perceived effects at the molecular level,” commented Chittiboyina.

The magic key: CB1 receptor

At the core of the study is cannabinoid receptor type 1 (CB1), a protein that is found throughout the body and regulates pain, mood, appetite, metabolism, and memory.

Both CBD and THC interact with this receptor, but they do so in distinctly different ways.

When THC binds to CB1, it acts like an “off switch” for pain, providing relief but often leading to side effects such as memory loss, nausea, and addiction.

CBD, on the other hand, behaves more like a dimmer switch, as it delicately modulates the receptor’s function.

This newfound understanding paves the way for future research aimed at harnessing the benefits of THC while minimizing its drawbacks.

The future of cannabis research

“Often, to mitigate pain, patients combine opiates with cannabis, kratom, and other substances. Is this approach beneficial or detrimental?” asked Chittiboyina, highlighting the many research opportunities that lie ahead.

The findings could even pave the way for the development of a more efficient, synthetic form of CBD that is designed to optimize receptor interactions while reducing unwanted effects.

This research goes beyond viewing cannabis merely as a drug – it positions the substance as a “treasure chest” of medicinal advances.

“We’re trying to pull out the benefits and leave the harms behind,” said Robert Laprairie, an associate professor at the University of Saskatchewan, and co-author of the study.

One of the next research frontiers involves investigating whether CBD interferes with opioids like morphine.

If CBD negatively interacts with opioid receptors, it could reduce the efficacy of opioids, which is a potential concern for individuals who rely on opioids for pain relief.

CBD research’s promising path

While these findings provide a foundation for understanding CBD’s therapeutic potential, the researchers emphasize that further studies are necessary before drawing definitive conclusions.

“But, if we can pinpoint how CBD interacts with multiple targets on a molecular level, we will be in a stronger scientific position to develop solutions that are relevant to public health,” the team concluded.

Their discoveries not only deepen our understanding of cannabis compounds but also open doors for targeted drug development aimed at reducing the risks associated with THC and opioids.

The study marks an important step toward safer and more effective treatment options for those suffering pain and struggling with mood disorders.

—–

The research was supported by grants from the National Institute of General Medical Sciences, the National Science Foundation XSEDE Bridges, and the Mississippi State-sponsored National Center for Cannabis Research and Education.

The full study was published in the journal ACS Chemical Neuroscience.

—–

Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

—–